Screener
Ginkgo Bioworks DNA Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $3.23M-46.9% | $3.6M-40.9% | —— | $5.74M-37.9% | $6.08M-41.0% | ||
| $20.16M-48.5% | $19.47M-49.1% | $33.4M-23.8% | $38.84M-56.4% | $39.13M-30.4% | ||
| $1.72M-68.0% | $3.1M-24.3% | —— | —— | $5.38M— | ||
| $18.44M-45.4% | $16.38M-52.0% | —— | —— | $33.75M— | ||
| 91.5%+5.2pp | 84.1%-5.2pp | —— | —— | 86.3%— | ||
| $46.21M-13.4% | $49.92M-29.6% | $50.13M-34.4% | $69.35M-9.9% | $53.37M-60.2% | ||
| $30.78M-12.0% | $37.83M-4.8% | $46.01M-19.7% | $44.95M-14.0% | $34.98M-47.2% | ||
| $78.7M-19.1% | $90.85M-23.8% | —— | —— | $97.3M— | ||
| -$58.55M-0.7% | -$71.37M+11.9% | -$70.75M+31.7% | -$90.02M-63.1% | -$58.16M+73.9% | ||
| -290.5%-142pp | -366.5%-155pp | -211.9%+24.4pp | -231.8%-170pp | -148.6%+248pp | ||
| $1.36M-71.1% | -$4.77M-112% | —— | $9.26M+689% | $4.69M-21.3% | ||
| -$57.19M-6.9% | -$76.14M+8.5% | -$81.39M+24.5% | -$80.75M-42.2% | -$53.48M+75.4% | ||
| $128K+145% | -$80K-191% | -$643K-97.8% | $1K+100% | -$283K-249% | ||
| -$46.71M+22.5% | -$82.59M+9.2% | -$80.75M+24.9% | -$80.76M-43.2% | -$60.3M+72.2% | ||
| -231.7%-77.7pp | -424.1%-186pp | -241.8%+3.4pp | -207.9%-145pp | -154.1%+232pp | ||
| -$46.23M-7.7% | -$58.58M+11.5% | -$57.09M+35.1% | -$74.76M-96.6% | -$42.91M+79.1% | ||
| -229.4%-120pp | -300.8%-128pp | -170.9%+29.6pp | -192.5%-150pp | -109.7%+256pp | ||
| -$58.55M-0.7% | -$71.37M+11.9% | -$70.75M+31.7% | -$90.02M-63.1% | -$58.16M+73.9% |
FAQ
- What is Ginkgo Bioworks's revenue?
- Ginkgo Bioworks (DNA) generated $111.9M in revenue over the trailing twelve months, down 46.8% year over year.
- Is Ginkgo Bioworks profitable?
- Ginkgo Bioworks is not currently profitable: it reported a net loss of $290.8M over the trailing twelve months, a -260.0% net margin.
- What are Ginkgo Bioworks's profit margins?
- Gross margin is 91.8% and operating margin is -259.9%, with a -260.0% net margin.
- Where does Ginkgo Bioworks's income statement data come from?
- Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
